OXAPEX Trademark

Trademark Overview

On Friday, December 13, 2013, a trademark application was filed for OXAPEX with the United States Patent and Trademark Office. The USPTO has given the OXAPEX trademark a serial number of 86143332. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 31, 2017. This trademark is owned by First Gain International Limited. The OXAPEX trademark is filed in the Pharmaceutical Products category with the following description:

Human and veterinary pharmaceutical preparations for the prevention and treatment of cardiovascular disorders, tissue hypoxia, shock and anemia; Human and veterinary pharmaceutical preparations to increase plasma oxygen content; biological preparations for medical and veterinary purposes, namely, sterile solutions for use in oxygen therapeutics; biological preparations for medical and veterinary purposes, namely, Hemoglobin solution for pharmaceutical purpose, and intravenous infusion solutions of a synthetic colloids and crystalloids; Biological preparations for medical and veterinary purposes, naming, protein, biological tissue cultures, blood, blood plasma, and serums
oxapex

General Information

Serial Number86143332
Word MarkOXAPEX
Filing DateFriday, December 13, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 31, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 29, 2014

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of stylized characters of "Oxapex" with the letter "a" replaced with the Greek letter alpha.
Goods and ServicesHuman and veterinary pharmaceutical preparations for the prevention and treatment of cardiovascular disorders, tissue hypoxia, shock and anemia; Human and veterinary pharmaceutical preparations to increase plasma oxygen content; biological preparations for medical and veterinary purposes, namely, sterile solutions for use in oxygen therapeutics; biological preparations for medical and veterinary purposes, namely, Hemoglobin solution for pharmaceutical purpose, and intravenous infusion solutions of a synthetic colloids and crystalloids; Biological preparations for medical and veterinary purposes, naming, protein, biological tissue cultures, blood, blood plasma, and serums

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 28, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFirst Gain International Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHong Kong
HK
Party NameFirst Gain International Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHong Kong
HK

Trademark Events

Event DateEvent Description
Thursday, August 10, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 10, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 31, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 31, 2017ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 7, 2017EXTENSION 5 GRANTED
Tuesday, December 27, 2016EXTENSION 5 FILED
Monday, February 27, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 10, 2017NOTICE OF REVIVAL - E-MAILED
Thursday, February 9, 2017EXTENSION RECEIVED WITH TEAS PETITION
Thursday, February 9, 2017PETITION TO REVIVE-GRANTED
Thursday, February 9, 2017TEAS PETITION TO REVIVE RECEIVED
Monday, January 30, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 30, 2017ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 12, 2016EXTENSION 4 GRANTED
Wednesday, June 22, 2016EXTENSION 4 FILED
Wednesday, June 22, 2016TEAS EXTENSION RECEIVED
Friday, January 22, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 21, 2016EXTENSION 3 GRANTED
Thursday, December 17, 2015EXTENSION 3 FILED
Thursday, December 17, 2015TEAS EXTENSION RECEIVED
Tuesday, July 7, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 6, 2015EXTENSION 2 GRANTED
Monday, June 22, 2015EXTENSION 2 FILED
Monday, June 22, 2015TEAS EXTENSION RECEIVED
Thursday, March 19, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 18, 2015EXTENSION 1 GRANTED
Wednesday, December 24, 2014EXTENSION 1 FILED
Wednesday, March 18, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 4, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 28, 2015NOTICE OF REVIVAL - E-MAILED
Wednesday, January 28, 2015EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, January 28, 2015PETITION TO REVIVE-GRANTED
Wednesday, January 28, 2015TEAS PETITION TO REVIVE RECEIVED
Monday, January 26, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 26, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 24, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 29, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 29, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 9, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 22, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 22, 2014ASSIGNED TO EXAMINER
Saturday, December 28, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 17, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

oxapex preparations veterinary biological purposes medical pharmaceutical human namely solutions plasma